These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15220276)

  • 1. Seroconversion of GAD antibody in unclassified diabetes with long duration of disease.
    Shigihara T; Shimada A; Saisho Y; Kawai T; Maruyama H; Saruta T
    Diabetes Care; 2004 Jul; 27(7):1836-7. PubMed ID: 15220276
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical heterogeneity of patients with adult-onset diabetes and GAD autoantibodies.
    Fukui M; Kitagawa Y; Nakamura N; Yoshikawa T
    Diabetes Care; 2002 Dec; 25(12):2363-4; author reply 2364-5. PubMed ID: 12453997
    [No Abstract]   [Full Text] [Related]  

  • 3. GAD antibodies in IDDM in Thailand.
    Rattarasarn C; Aguilar-Diosdado M; Soonthornpun S; Patarakijvanich N; Jaruratanasirikul S
    Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
    [No Abstract]   [Full Text] [Related]  

  • 4. Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
    Nagai T; Imamura M; Mori M
    Intern Med; 2005 Apr; 44(4):299-302. PubMed ID: 15897639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to GAD in elderly patients with previously diagnosed NIDDM.
    Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M
    Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369
    [No Abstract]   [Full Text] [Related]  

  • 6. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
    Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
    [No Abstract]   [Full Text] [Related]  

  • 7. GAD antibody in multiplex diabetic pedigrees of Chinese.
    Chen T; Ren Y; Long Y; Zhang X; Yu H; Tian H
    Diabetes Care; 2007 Dec; 30(12):3091-2. PubMed ID: 17878243
    [No Abstract]   [Full Text] [Related]  

  • 8. [A 81-year-old case of latent autoimmune diabetes mellitus in adult].
    Wang TQ; Liu YS; Qu GY; Xiao X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):369. PubMed ID: 16136990
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.
    Bárová H; Perusicová J; Hill M; Sterzl I; Vondra K; Masek Z
    Physiol Res; 2004; 53(3):279-86. PubMed ID: 15209535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 13. GAD antibodies in classification of Asian type 2 diabetes.
    Fukui M; Nakamura N; Kondo M
    Diabetes Care; 1999 Jun; 22(6):1011-2. PubMed ID: 10372266
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate and its effect on the anti-GAD titre in two patients with rheumatoid arthritis and diabetes mellitus.
    van Deutekom AW; Nurmohamed MT; Peters MJ; van Eijk IC; Dijkmans BA; Hamann D; Heine RJ; Simsek S
    Ann Rheum Dis; 2008 Jul; 67(7):1051-2. PubMed ID: 18556448
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 16. [When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?].
    Atlan-Gepner C; Vialettes B
    Diabetes Metab; 1999 Jun; 25(2):177-9. PubMed ID: 10443330
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas.
    Taniguchi T; Okazaki K; Okamoto M; Seko S; Uchida K; Seino Y
    Diabetes Care; 2001 Sep; 24(9):1695-6. PubMed ID: 11522728
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
    Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.